Ninsun Biotech: a Valais innovation in the fight against cancer
Based at the BioArk Monthey technology park and supported by the Ark incubator, Ninsun Biotech is developing a platform for detecting cancer stem cells (CSCs) based on glycan pattern recognition. This technology, clinically validated in lung and colorectal cancers, aims to optimize patient stratification, therapeutic monitoring, and accelerate the development of new molecules in oncology.
Ninsun Biotech: a Valais innovation in the fight against cancer Read More »